Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Retina (Philadelphia, Pa.)|November 28, 2007
Intravitreal bevacizumab (avastin) in central retinal vein occlusionJason Hsu, Richard S Kaiser, Arunan Sivalingam, et al.
Clinical and Experimental Rheumatology|January 14, 2025
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patientsYusuf Yazici, Jeyanesh R S Tambiah, Christopher J Swearingen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2005
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetesFrauke Fehse, Michael Trautmann, Jens J Holst, et al.
Retinal Cases & Brief Reports|August 16, 2022
NODULAR EPIRETINAL MÜLLER CELL GLIOSIS IN THE FOVEAJesse J Jung, Anne Zeng, Rahul Komati, et al.
Metabolism: Clinical and Experimental|April 30, 2002
Glucoregulatory endocrine responses to intermittent exercise of different intensities: plasma changes in a pancreatic beta-cell peptide, amylinR R Kraemer, E O Acevedo, L B Synovitz, et al.
Clinical Pharmacology and Therapeutics|July 17, 2007
Pharmacometrics and the transition to model-based developmentT H Grasela, C W Dement, O G Kolterman, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 7, 2007
Postoperative complications associated with 25-gauge pars plana vitrectomyOmesh P I Gupta, Eric D Weichel, Carl D Regillo, et al.
Retina (Philadelphia, Pa.)|September 2, 2006
Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 yearsBernard R Hurley, J Arch McNamara, Mitchell S Fineman, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 14, 2015
Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case seriesDavid A Salz, John D Pitcher, Jason Hsu, et al.
Diabetes, Obesity & Metabolism|June 28, 2023
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrationsMark S Fineman, Christine L N Bryant, Kevin Colbert, et al.
Pageof 9